Novel drug target may help overcome resistance to EZH2 inhibitors in SMARCB1 mutated cancers
Inhibitors of the protein EZH2 are effective against cancers with SMARCB1 mutations such as rhabdoid tumors in children.
Source: news-medical.net
📰 Emma Beane News
Emma Beane News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Emma Beane. Real-time updates on events, politics, business and more.